glp-1 drugs cancer May Protect Against Cancer— Here's What That Means For Public Health Glucagon-like peptide 1 receptor agonists

using liraglutide 3 mg/day compared with placebo, despite the lack of changes in total testosterone levels, confirmed the increase in SHBG levels, with a consequent reduction in free Androgen Index (FAI), and also a restoration in menstrual cyclicity [62]

Nissen, who serves as study co-chair of SURMOUNT-MMO, notes that the exclusion of patients with diabetes will avoid confounding of results by favorable outcomes due to tirzepatides antidiabetic effects

Changshu Hospital Affiliated to Soochow University, Changshu No.1 People's Hospital, Changshu 215500, Jiangsu Province, China

Relationship between body weight change and glycemic control with tirzepatide treatment in people with type 2 diabetes (abstract)

According to the company's About page, the Joi brand was created by co-founder Katy Whalen to "give women what I never had - a space to feel heard, supported, and empowered with the kind of care that's built for women, by women." Women considering GLP-1 medications may have questions related to hormonal interactions, perimenopause, menopause, or conditions like PCOS